DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
Clinical trial NCT06173310 · RECRUITING
Trial details
- NCT number
- NCT06173310
- Sponsor
- Ohio State University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2029-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.